SCHEMBL8203152

SCHEMBL8203152

CN1CCN(c2ccc3c(c2)CN(C(=O)O)C3)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 11/20 0.63
SIGMAR1 Q99720 11/20 0.63
HRH1 P35367 3/20 0.63
HRH3 Q9Y5N1 3/20 0.63
HRH2 P25021 2/20 0.63
HTR1A P08908 1/20 0.63
ADRA2A P08913 1/20 0.63
ADRA2B P18089 1/20 0.63
ADRA2C P18825 1/20 0.63
DRD1 P21728 1/20 0.63
HTR1B P28222 1/20 0.63
HTR2A P28223 1/20 0.63
HTR2C P28335 1/20 0.63
HTR1E P28566 1/20 0.63
SLC6A4 P31645 1/20 0.63
HTR2B P41595 1/20 0.63
RORC P51449 1/20 0.48
ABHD6 Q9BV23 4/20 0.48
CHRM1 P11229 1/20 0.47
SLC6A2 P23975 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8203214 0.87 ABHD6 (0.60) TMEM97SIGMAR1HRH1HRH3HRH2
SCHEMBL5198323 0.85 ABHD6 (0.64) TMEM97SIGMAR1HRH1HRH3HRH2
SCHEMBL14959461 0.84 TMEM97 (0.66) TMEM97SIGMAR1HRH1HRH3HRH2
SCHEMBL12187763 0.81 TMEM97 (0.74) TMEM97SIGMAR1HRH1HRH3HRH2
SCHEMBL12572451 0.81 TMEM97 (0.56) TMEM97SIGMAR1HRH1HRH3HRH2
SCHEMBL383293 0.80 TMEM97 (0.62) TMEM97SIGMAR1HRH1HRH3HRH2
SCHEMBL19521478 0.78 TMEM97 (1.00) TMEM97SIGMAR1HRH1HRH3HRH2
SCHEMBL20983740 0.77 ABHD6 (0.82) TMEM97SIGMAR1HRH1HRH3HRH2
SCHEMBL2814463 0.77 KMT2A (0.57)
SCHEMBL14232595 0.77 KDM4E (0.53) TMEM97SIGMAR1HRH1HRH3HRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020227368-A1 HSP90 INHIBITORS AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2020-11-12 WO disclosed
WO-2008033389-A2 MACROCYCLIC HCV INHIBITORS AND THEIR USES NOVARTIS AG (CH) 2008-03-20 WO disclosed
WO-2007133865-A2 HCV/HIV INHIBITORS AN THEIR USES NOVARTIS AG (CH) 2007-11-22 WO disclosed